The Manufacturers Life Insurance Company Boosts Holdings in Core Scientific, Inc. $CORZ

Posted by Brenda Bartman on Aug 10th, 2026

The Manufacturers Life Insurance Company boosted its holdings in shares of Core Scientific, Inc. (NASDAQ:CORZ – Free Report) by 45.8% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 139,102 shares of the company’s stock after buying an additional 43,697 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Core Scientific were worth $2,081,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Allworth Financial LP boosted its stake in shares of Core Scientific by 206.5% during the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after acquiring an additional 950 shares during the last quarter. Larson Financial Group LLC raised its holdings in Core Scientific by 936.7% in the 4th quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock worth $27,000 after purchasing an additional 1,686 shares during the period. Osaic Holdings Inc. raised its holdings in Core Scientific by 112.1% in the 2nd quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock worth $34,000 after purchasing an additional 1,066 shares during the period. Danske Bank A S purchased a new position in Core Scientific during the fourth quarter valued at $36,000. Finally, Russell Investments Group Ltd. grew its holdings in Core Scientific by 61.9% during the second quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company’s stock valued at $67,000 after purchasing an additional 1,507 shares during the period.

Core Scientific Price Performance

Shares of Core Scientific stock opened at $21.01 on Monday. The company has a market capitalization of $6.75 billion, a price-to-earnings ratio of -4.75 and a beta of 5.59. The stock’s 50-day simple moving average is $24.59 and its 200-day simple moving average is $20.96. Core Scientific, Inc. has a 52 week low of $13.14 and a 52 week high of $30.46.

Core Scientific (NASDAQ:CORZ – Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The company had revenue of $164.20 million during the quarter, compared to analysts’ expectations of $144.83 million. On average, equities analysts expect that Core Scientific, Inc. will post -1.36 earnings per share for the current year.

Insiders Place Their Bets

In other Core Scientific news, insider Todd M. Duchene sold 10,000 shares of the stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $22.23, for a total transaction of $222,300.00. Following the completion of the sale, the insider directly owned 1,979,101 shares of the company’s stock, valued at $43,995,415.23. This trade represents a 0.50% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In the last ninety days, insiders sold 90,000 shares of company stock valued at $2,248,600. Corporate insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on CORZ. Lucid Cap Mkts upgraded Core Scientific to a “strong-buy” rating in a research report on Friday, June 12th. Loop Capital set a $40.00 price objective on Core Scientific in a research report on Friday, June 12th. Compass Point reissued a “buy” rating and issued a $36.00 target price on shares of Core Scientific in a report on Wednesday, July 29th. Keefe, Bruyette & Woods upgraded shares of Core Scientific from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $25.00 to $28.00 in a research note on Thursday, July 30th. Finally, Wolfe Research reaffirmed a “buy” rating on shares of Core Scientific in a report on Wednesday, July 29th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $32.18.

Check Out Our Latest Analysis on CORZ

Core Scientific Profile

(Free Report)

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.